Homepage /  About


Israel’s biotechnology investment hub

Clal Biotechnology Industries (TASE: CBI) is Israel’s largest life sciences investment company. CBI is focused on identifying and supporting promising innovative ventures, developing proprietary solutions, addressing unmet medical needs with multibillion dollar market potential.

With offices in Tel-Aviv and Boston, we provide our companies access to the global biotechnology industry.

We invest in companies ranging from seed to maturity, both public and private. We apply diverse models of strategic cooperation, providing significant investments together with hands-on leadership and guidance.

Powering life sciences solutions

CBI’s investments range from biotech and pharma to diagnostics and medical devices.

Our team maximizes the value of existing investments,  contributes to the development of investee companies and finds new investments and business opportunities with great potential returns in Israel and the United States.

Our Stockholders

Clal Industries Ltd. is one of Israel’s leading investment companies. It holds a portfolio of investments from heavy industry to biotechnology, hi-tech and energy companies. Clal Industries is fully owned by Access Industries, a privately held industrial group with long-term holdings worldwide.


Access Industries is a privately held industrial group with long-term holdings in the sectors of natural resources and chemical, media and telecommunications, venture capital and real estate. Founded in 1986 by Len Blavatnik, an American and British entrepreneur and philanthropist, Access is an international industrial concern with strategic investments worldwide.